M
Miriam C. Poirier
Researcher at National Institutes of Health
Publications - 218
Citations - 9055
Miriam C. Poirier is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Zidovudine & DNA adduct. The author has an hindex of 54, co-authored 218 publications receiving 8746 citations. Previous affiliations of Miriam C. Poirier include National Institute for Occupational Safety and Health.
Papers
More filters
Book ChapterDOI
Chemical carcinogenesis: from animal models to molecular models in one decade.
TL;DR: The rasH gene (and perhaps other members of the ras gene family) appears to be a common target for coding sequence mutations in the initiation of carcinogenesis in several organ sites and species by specific carcinogens.
Journal ArticleDOI
Chemical-induced DNA damage and human cancer risk
TL;DR: Gaining better insight into the mechanisms by which PAH exposure might increase oesophageal cancer risk could lead to new strategies for cancer prevention.
Journal ArticleDOI
Transplacental Effects of 3′-Azido-2′,3′-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and Monkeys
Ofelia A. Olivero,Stuart H. Yuspa,Miriam C. Poirier,Lucy M. Anderson,Ann B. Jones,Chaoyu Wang,Bhalchandra A. Diwan,Diana C. Haines,Daniel Logsdon,Steven W. Harbaugh,Thomas J. Moskal,Jerry M. Rice,Charles W. Riggs +12 more
TL;DR: AZT is genotoxic in fetal mice and monkeys and is a moderately strong transplacental carcinogen in mice examined at 1 year of age, and careful long-term follow-up of AZT-exposed children would seem to be appropriate.
Journal ArticleDOI
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.
TL;DR: In ovarian cancer patients, the formation of the intrastrand diammineplatinum adducts in leukocyte DNA is associated with favorable disease response to cis-diamminedichloroplatinum (II) or diamminecyclobutane-dicarboxylatoplatinum chemotherapy.
Journal ArticleDOI
Carcinogen macromolecular adducts and their measurement
TL;DR: Integration of DNA and protein adduct measurements together with documentation of correlative and subsequent events, and host susceptibility factors, within the context of valid molecular epidemiologic study designs, will further the understanding of human disease mechanisms.